Vasco Pharma SRL
Vasco Pharma reported total assets of €2.07m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Vasco Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -12 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vasco Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 06 Oct 2022
Vasco Pharma's financial analysis
- Solvency42.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vasco Pharma
Vasco Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0870.190.760
- VAT number
- BE0870190760
- Peppol
- Registered · 0208:0870190760 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Nov 2004
- Registered office
- 2550 Kontich
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Vasco Pharma (SRL) has been based in Kontich since 2004, active in: activities of holding companies. For 2025, it reports a net profit of 59,969 € and equity of 877,633 €; its revenue is not published. Its solvency stands at 42.4%, below the median of its sector (55.6%).
Companies similar to Vasco Pharma
Companies in the same business, of comparable size and area, outside its group.
- THE Global Transport Group Activities of holding companies Ardooie · balance sheet €2.09m
- VH-H Invest Activities of holding companies Pittem · balance sheet €2.12m
- Intermedia Activities of holding companies Heusden-Zolder · balance sheet €1.94m
- Giwe Activities of holding companies Beveren-Kruibeke-Zwijndrecht · balance sheet €1.78m
- DE Bauw Activities of holding companies Asse · balance sheet €2.48m
- Bemako Holding Activities of holding companies Zemst · balance sheet €1.65m
- Van de Velde - Matthijs Activities of holding companies Oostkamp · balance sheet €2.64m
- Holimmo Activities of holding companies Hoogstraten · balance sheet €2.64m
Frequently asked questions about Vasco Pharma
What is the revenue of Vasco Pharma?
Vasco Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vasco Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0870190760 for Vasco Pharma, if the company is VAT-registered. Its company number (CBE) is 0870.190.760.
Where is the registered office of Vasco Pharma?
According to the CBE register, the registered office of Vasco Pharma is in 2550 Kontich.
What is the equity of Vasco Pharma?
At the close of the 2025 financial year, the equity of Vasco Pharma amounts to 877,633 €, a solvency of 42.4% of total assets.
Who manages Vasco Pharma?
The register lists 1 active mandates at Vasco Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vasco Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →